Cargando…

Health-related quality of life in end-stage renal disease patients, using the Missoula-Vitas quality of life index: a multicenter study

BACKGROUND AND AIMS: Assessment of Health-related Quality of Life in chronic hemodialysis patients (CHD) is a predictive indicator of the outcome of the disease, including mortality and hospitalization. Regular surveys of the quality of life (QoL) in CHD patients have been conducted worldwide, using...

Descripción completa

Detalles Bibliográficos
Autores principales: Dimova, Rositsa, Keskinova, Donka, Tzekov, Valeri, Ginova-Noncheva, Gergana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Iuliu Hatieganu University of Medicine and Pharmacy 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6853037/
https://www.ncbi.nlm.nih.gov/pubmed/31750438
http://dx.doi.org/10.15386/mpr-1320
_version_ 1783469972559757312
author Dimova, Rositsa
Keskinova, Donka
Tzekov, Valeri
Ginova-Noncheva, Gergana
author_facet Dimova, Rositsa
Keskinova, Donka
Tzekov, Valeri
Ginova-Noncheva, Gergana
author_sort Dimova, Rositsa
collection PubMed
description BACKGROUND AND AIMS: Assessment of Health-related Quality of Life in chronic hemodialysis patients (CHD) is a predictive indicator of the outcome of the disease, including mortality and hospitalization. Regular surveys of the quality of life (QoL) in CHD patients have been conducted worldwide, using various, internationally validated and standardized tools, including the Missoula-VITAS Quality of Life Index scale (MVQOLI). The aim of this study was to examine the reliability and validity of the Bulgarian version of the Missoula-VITAS Quality of Life Index-15 (B-MVQOLI-15) and QoL in CHD patients using this instrument. METHODS: Our study was designed as multi-center cross-sectional. It incorporated 263 end-stage renal disease (ESRD) patients on CHD from across the country and applied the B-MVQOLI-15. Internal consistency and convergent validity of the index were assessed. Non-parametric methods were used to evaluate the impact of demographic factors on the different dimensions scores and on the total score. The relationship between the total QoL score, the total MVQOLI-15 score and dimensions scores were measured based on Spearman’s rho Correlation Coefficient. RESULTS: The total MVQOLI-15 score in the study was 16.44, which is slightly above the middle of the index scale. The patients with higher education were less satisfied with the level of their symptom control compared to patients with lower education. However, high education patients seem to manage better with everyday life compared to those with low education. Men seem to feel more satisfied than women when fulfilling their daily activities (P=0.026). Retired patients and unemployed expressed more satisfaction, compared to the employed (P=0.021). Also, patients on dialysis for over 5 years had lower QoL scores (P=0.043). CONCLUSIONS: B-MVQOLI-15 is a reliable instrument to measure QoL in Bulgarian patients with CHD. The majority of CHD patients rate their QoL as “Fair”. Four of all five dimensions positively affect the QoL of CHD patients. The most important dimensions positively affecting the QoL of CHD patients were: interpersonal relationships and transcendent factors. Future studies are necessary to assess the adequacy of the delivered dialysis, the level of medico-social care and the needs of ESRD patients treated with CHD in order to improve their QoL.
format Online
Article
Text
id pubmed-6853037
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Iuliu Hatieganu University of Medicine and Pharmacy
record_format MEDLINE/PubMed
spelling pubmed-68530372019-11-20 Health-related quality of life in end-stage renal disease patients, using the Missoula-Vitas quality of life index: a multicenter study Dimova, Rositsa Keskinova, Donka Tzekov, Valeri Ginova-Noncheva, Gergana Med Pharm Rep Original Research BACKGROUND AND AIMS: Assessment of Health-related Quality of Life in chronic hemodialysis patients (CHD) is a predictive indicator of the outcome of the disease, including mortality and hospitalization. Regular surveys of the quality of life (QoL) in CHD patients have been conducted worldwide, using various, internationally validated and standardized tools, including the Missoula-VITAS Quality of Life Index scale (MVQOLI). The aim of this study was to examine the reliability and validity of the Bulgarian version of the Missoula-VITAS Quality of Life Index-15 (B-MVQOLI-15) and QoL in CHD patients using this instrument. METHODS: Our study was designed as multi-center cross-sectional. It incorporated 263 end-stage renal disease (ESRD) patients on CHD from across the country and applied the B-MVQOLI-15. Internal consistency and convergent validity of the index were assessed. Non-parametric methods were used to evaluate the impact of demographic factors on the different dimensions scores and on the total score. The relationship between the total QoL score, the total MVQOLI-15 score and dimensions scores were measured based on Spearman’s rho Correlation Coefficient. RESULTS: The total MVQOLI-15 score in the study was 16.44, which is slightly above the middle of the index scale. The patients with higher education were less satisfied with the level of their symptom control compared to patients with lower education. However, high education patients seem to manage better with everyday life compared to those with low education. Men seem to feel more satisfied than women when fulfilling their daily activities (P=0.026). Retired patients and unemployed expressed more satisfaction, compared to the employed (P=0.021). Also, patients on dialysis for over 5 years had lower QoL scores (P=0.043). CONCLUSIONS: B-MVQOLI-15 is a reliable instrument to measure QoL in Bulgarian patients with CHD. The majority of CHD patients rate their QoL as “Fair”. Four of all five dimensions positively affect the QoL of CHD patients. The most important dimensions positively affecting the QoL of CHD patients were: interpersonal relationships and transcendent factors. Future studies are necessary to assess the adequacy of the delivered dialysis, the level of medico-social care and the needs of ESRD patients treated with CHD in order to improve their QoL. Iuliu Hatieganu University of Medicine and Pharmacy 2019-10 2019-10-25 /pmc/articles/PMC6853037/ /pubmed/31750438 http://dx.doi.org/10.15386/mpr-1320 Text en This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (http://creativecommons.org/licenses/by-nc-nd/4.0/)
spellingShingle Original Research
Dimova, Rositsa
Keskinova, Donka
Tzekov, Valeri
Ginova-Noncheva, Gergana
Health-related quality of life in end-stage renal disease patients, using the Missoula-Vitas quality of life index: a multicenter study
title Health-related quality of life in end-stage renal disease patients, using the Missoula-Vitas quality of life index: a multicenter study
title_full Health-related quality of life in end-stage renal disease patients, using the Missoula-Vitas quality of life index: a multicenter study
title_fullStr Health-related quality of life in end-stage renal disease patients, using the Missoula-Vitas quality of life index: a multicenter study
title_full_unstemmed Health-related quality of life in end-stage renal disease patients, using the Missoula-Vitas quality of life index: a multicenter study
title_short Health-related quality of life in end-stage renal disease patients, using the Missoula-Vitas quality of life index: a multicenter study
title_sort health-related quality of life in end-stage renal disease patients, using the missoula-vitas quality of life index: a multicenter study
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6853037/
https://www.ncbi.nlm.nih.gov/pubmed/31750438
http://dx.doi.org/10.15386/mpr-1320
work_keys_str_mv AT dimovarositsa healthrelatedqualityoflifeinendstagerenaldiseasepatientsusingthemissoulavitasqualityoflifeindexamulticenterstudy
AT keskinovadonka healthrelatedqualityoflifeinendstagerenaldiseasepatientsusingthemissoulavitasqualityoflifeindexamulticenterstudy
AT tzekovvaleri healthrelatedqualityoflifeinendstagerenaldiseasepatientsusingthemissoulavitasqualityoflifeindexamulticenterstudy
AT ginovanonchevagergana healthrelatedqualityoflifeinendstagerenaldiseasepatientsusingthemissoulavitasqualityoflifeindexamulticenterstudy